The physiological basis of our model is the reaction diagram [Figure 1] and the K m values for the enzymes
Disclosure of interest: Nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.01 - PREVENTION P2471 - ESOC25-388 COMPARARIVE EFFECTIVENESS AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN ATRIAL FIBRILLATION PATIENTS WITH DEMENTIA Sheng-Feng Sung 1 , Cheng-Yang Hsieh 2 , Hsin-Yi Yang 3 , Chen-Wen Fang 4,5 1 Division of Neurology, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan, 2 Department of Neurology, Tainan Sin Lau Hospital, Tainan City, Taiwan, 3 Clinical Data Center, Department of Medical Research, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan, 4 Department of Neurology, National Taiwan University Hospital, Yunlin branch, Douliu City, Taiwan, 5 Department of Biomedical Engineering, National Cheng Kung University., Tainan City, Taiwan Background and Aims: Stroke or systemic embolism is the most severe complication of atrial fibrillation (AF)
Both peptides require proper reconstitution with bacteriostatic water, refrigerated storage at 28C, and third-party purity verification
National news coverage of peptides in 2026, including the PBS NewsHour reporting on the FDA reconsideration of restrictions on compounded peptides, has put these compounds in front of millions of people who never heard of them before
